HIV :: AHF Welcomes FDA Approval of Pfizer?s Selzentry AIDS Drug

On the heels of the fourth International AIDS Society?s Conference on HIV Pathogenesis, Treatment and Prevention, which took place in Sydney in late July, AIDS Healthcare Foundation (AHF) welcomed yesterday?s news that the FDA has approved Pfizer Inc.?s new AIDS salvage therapy, Selzentry (maraviroc), a different class of new antiretroviral AIDS drug which had been discussed and presented at the IAS conference.

Menopause :: Grapes, Soy and Kudzu Blunt Some Menopausal Side Effects

Menopausal women are at relatively high risk for memory loss, high blood pressure (hypertension) and diabetes. A decade ago, the standard treatment for these problems was long-term hormone replacement therapy (HRT). Since then, studies have shown that extensive use of HRT is associated with significant adverse effects.

HPV :: Milestones achieved in HPV Immunization for cervical cancer, Canada

On July_10, 2006, Health Canada approved GARDASIL(R), (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine), the first and only vaccine uniquely designed for the prevention of cervical, vulvar and vaginal cancers, as well as precancerous lesions at these sites and genital warts caused by HPV types 6, 11, 16 and 18. Since becoming available in pharmacies across the country, over 100,000 doses of the vaccine have been distributed.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack